AI-generated · cited to primary sources · not investment advice
Unihealth Hosp (UNIHEALTH) Nov 2025 Filing Analysis
Does management do what it says?
The Navi Mumbai facility launch was delayed from the original July 2025 target to October 2025 due to statutory approval delays during the festive season. (2 revised across 2 tracked commitments)
“Navi Mumbai, we had anticipated it to be operational by July. We became operational in the first week of October. Actually, in Dussehra we did a soft launch and we became operational. The delay was due to certain statutory approvals, which took time.”
See the full cited Management analysis of Unihealth Hosp
How durable is the business?
The Medical Value Travel (MVT) and distribution moat is being strengthened through new airline partnerships (Myanmar Airways) and a focus on the Africa-India medical corridor. (1 expanding)
“UniHealth and Myanmar Airways International launch the UniHealth - MAI Medical Travel Program.”
Uganda remains the dominant revenue driver, contributing 90% of H1 revenue. Occupancy improved from 62.5% to 72%, and ARPOB jumped significantly from ~25,000 to over 40,000. (1 expanding)
“89% plus revenue contribution has come in from the Ugandan unit... Occupancy in H1 was roughly around 72%... last year, H1, the occupancy was somewhere around 62%-63%.”
See the full cited Business Model analysis of Unihealth Hosp
What could break the thesis?
The risk is easing. Despite expansion, Net Profit Margin improved significantly to 21.72% in H1 FY26 from 11.43% in H1 FY25. Finance costs actually decreased from ₹1.91 Cr to ₹1.18 Cr year-on-year. (1 easing, 1 stable)
“Net Profit Margin (%) H1 FY25 11.43, H1 FY26 21.72; Finance Costs H1 FY25 1.91, H1 FY26 1.18”
See the full cited Risk analysis of Unihealth Hosp
AI-generated informational research only. ThesisLoop is not investment advice, a stock recommendation, or a guarantee of returns.